Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results

Research in Nursing and Health

Volumn 34, Issue 5, 2011, Pages 389-400

  Tluczek, Audrey ^a,b   McKechnie, Anne Chevalier ^a   Brown, Roger L ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Congenital hypothyroidism; Cystic fibrosis; Genetic carriers; Newborn screening; Vulnerable child

Indexed keywords

ADULT; ARTICLE; CHILD CARE; CHILD PARENT RELATION; COMPARATIVE STUDY; CYSTIC FIBROSIS; FEMALE; HEALTH STATUS; HUMAN; HYPOTHYROIDISM; INFANT; MALE; METHODOLOGY; NEWBORN; NEWBORN SCREENING; OBJECT RELATION; PARENT; PSYCHOLOGICAL ASPECT; VULNERABLE POPULATION;

ADULT; CYSTIC FIBROSIS; FEMALE; HEALTH STATUS; HUMANS; HYPOTHYROIDISM; INFANT; INFANT CARE; INFANT, NEWBORN; MALE; NEONATAL SCREENING; OBJECT ATTACHMENT; PARENT-CHILD RELATIONS; PARENTS; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 80052673799     PISSN: 01606891     EISSN: 1098240X     Source Type: Journal    
DOI: 10.1002/nur.20452     Document Type: Article

References (49)

1. Abidin, R. R. (1995). Parenting stress index: Professional manual (3rd ed.). Lutz, FL: Psychological Assessment Resources.
2. Accurso, F. J. (2008). Update in cystic fibrosis 2007. American Journal of Respiratory and Critical Care Medicine, 177, 1058-1061. DOI: 10.1164/rccm.200801-069UP.
3. American Academy of Pediatrics Newborn Screening Task Force. (2000). Serving the family from birth to the medical home. Newborn screening: A blueprint for the future-A call for a national agenda on state newborn screening programs. Pediatrics, 106, 389-422. Retrieved from.
4. Bergman, A. B., & Stamm, S. J. (1967). The morbidity of cardiac nondisease in schoolchildren. New England Journal of Medicine, 276, 1008-1013. Retrieved from.
5. Castellani, C., Picci, L., Scarpa, M., Dechecchi, M. C., Zanolla, L., Assael, B. M., & Zacchello, F. (2005). Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogin values than non-carriers. American Journal of Medical Genetics. Part A, 135, 142-144. DOI: 10.1002/ajmg.a.30470.
6. Chan, I. S. F. (1998). Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Statistics in Medicine, 17, 1403-1413. DOI: 10.1002/(SICI)1097-0258(19980630)17:12<1403::AID.-SIM834>3.0.CO;2-Y.
7. Ciske, D. J., Haavisto, A., Laxova, A., Zeng, L., Rock, M., & Farrell, P. M. (2001). Genetic counseling and neonatal screening for cystic fibrosis: An assessment of the communication process. Pediatrics, 107, 699-705. DOI: 10.1542/peds.107.4.699.
8. Cystic Fibrosis Foundation Website (2/3/2011). Carriers of CF. Retrieved from About CF/.
9. Cytel Software Corporation. (2009). StatXact8. Cambridge, MA: Author.
10. De Ocampo, A. C., Macias, M. M., Saylor, C. F., & Katikaneni, L. D. (2003). Caretaker perception of child vulnerability predicts behavior problems in NICU graduates. Child Psychiatry and Human Development, 34, 83-96. DOI: 10.1023/A:1027384306827.
11. Dogan, D. G., Ertem, I. O., Karaaslan, T., & Forsyth, B. W. (2009). Perception of vulnerability among mothers of healthy infants in a middle-income country. Child: Care, Health and Development, 35, 868-872. DOI: 10.1111/j.1365-2214.2009.01015.x.
12. Farrell, P. M., & Koscik, R. E. (1996). Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics, 97, 524-528. Retrieved from.
13. Fedele, D. A., Grant, D. M., Wolfe-Christensen, C., Mullins, L. L., & Ryan, J. L. (2010). An examination of the factor structure of parenting capacity measures in chronic illness populations. Journal of Pediatric Psychology, 35, 1083-1092. DOI: 10.1093/jpepsy/jsq045.
14. Forsyth, B. W., Horwitz, S. M., Leventhal, J. M., Burger, J., & Leaf, P. J. (1996). The child vulnerability scale: An instrument to measure parental perceptions of child vulnerability. Journal of Pediatric Psychology, 21, 89-101. Retrieved from.
15. Gleason, T. R., & Evans, M. E. (2004). Perceived vulnerability: A comparison of parents and children. Journal of Child Health Care, 8, 279-287. DOI: 10.1177/1367493504047318.
16. Green, M., & Solnit, A. J. (1964). Reactions to the threatened loss of a child: A vulnerable child syndrome. Pediatric management of the dying child, Part III. Pediatrics, 34, 58-66. Retrieved from.
17. Gregg, R. G., Wilfond, B. S., Farrell, P. M., Laxova, A., Hassemer, D., & Mischler, E. H. (1993). Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): Comparison of screening protocols. American Journal of Human Genetics, 52, 616-626. Retrieved from.
18. Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006). Expanded newborn screening for biochemical disorders: The effect of a false-positive result. Pediatrics, 117, 1915-1921. DOI: 10.1542/peds.2005-2294.
19. Kemper, K., Forsyth, B., & McCarthy, P. (1989). Jaundice, terminating breast-feeding, and the vulnerable child. Pediatrics, 84, 773-778. Retrieved from.
20. Kerruish, N. J., Campbell-Stokes, P. L., Gray, A., Merriman, T. R., Robertson, S. P., & Taylor, B. J. (2007). Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics, 120, e324-e335. DOI: 10.1542/peds.2006-1381.
21. Lewis, S., Curnow, L., Ross, M., & Massie, J. (2006). Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. Journal of Paediatrics and Child Health, 42, 533-537. DOI: 10.1111/j.1440-1754.2006.00917.x.
22. Lipstein, E. A., Perrin, J. M., Waisbren, S. E., & Prosser, L. A. (2009). Impact of false-positive newborn metabolic screening results on early health care utilization. Genetics in Medicine, 11, 716-721. DOI: 10.1097/GIM.0b013e3181b3a61e.
23. Little, R. J. A. (1988). A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Association, 83, 1198-1202. Retrieved from.
24. MacKinnon, D. P. (2008). Introduction to statistical mediation analysis. New York, NY: Erlbaum.
25. Moran, J., Quirk, K., Duff, A. J. A., & Brownlee, K. G. (2007). Newborn screening for CF in a regional paediatric centre: The psychosocial effects of false-positive IRT results on parents. Journal of Cystic Fibrosis, 6, 250-254. DOI: 10.1016/j.jcf.2006.09.001.
26. Muthén, L. K., & Muthén, B. O. (1998-2010). Mplus user's guide. Los Angeles, CA: Author.
27. National Newborn Screening and Genetics Resource Center. (2009). National newborn screening status report. Retrieved from.
28. Nyström, K., & Öhrling, K. (2004). Parenthood experiences during the child's first year: Literature review. Journal of Advanced Nursing, 46, 319-330. DOI: 10.1111/j.1365-2648.2004.02991.x.
29. Parad, R. B., Comeau, A. M., Dorkin, H. L., Dovey, M., Gerstle, R., Martin, T., & O'Sullivan, B. P. (2005). Sweat testing infants detected by cystic fibrosis newborn screening. Journal of Pediatrics, 147(3 Suppl), S69-S72. DOI: 10.1016/j.jpeds.2005.08.015.
30. Perrin, E. C., West, P. D., & Culley, B. S. (1989). Is my child normal yet? Correlates of vulnerability. Pediatrics, 83, 355-363. Retrieved from.
31. Polit, D. F., & Beck, C. T. (2008). Nursing research: Generating and assessing evidence for nursing practice (8th ed.) Philadelphia, PA: Lippincott Williams & Wilkins.
32. Poulakis, Z., Barker, M., & Wake, M. (2003). Six month impact of false positives in an Australian infant hearing screening programme. Archives of Disease in Childhood, 88, 20-24. DOI: 10.1136/adc.88.1.20.
33. Ross, L. F., & Clayton, E. W. (2009). Clinical and ethical considerations in managing carrier detection. American Journal of Public Health, 99, 1348-1349. DOI: 10.2105/AJPH.2009.1 61554.
34. Schafer, J. L. (1999). 'NORM: Multiple imputation of incomplete multivariate data under a normal model, version 2.03', software for Windows 95/98/NT, available from.
35. Scotet, V., De Braekeleer, M., Audrézet, M.-P., Lodé, L., Verlingue, C., Quéré, I., Férec, C. (2001). Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Clinical Genetics, 59, 42-47. DOI: 10.1034/j.1399-0004.2001.590107.x.
36. Sidak, Z. (1967). Rectangular confidence regions for the means of multivariate normal distributions. Journal of the American Statistical Association, 62, 626-633. Retrieved from.
37. Soeken, K. L. (2010). Validity of measures. In: C. F. Waltz, O. L. Strickland, & E. R. Lenz (Eds.), Measurement in nursing and health research (4th ed., pp. 163-202). New York, NY: Springer.
38. Spurrier, N. J., Sawyer, M. G., Staugas, R., Martin, A. J., Kennedy, D., & Streiner, D. L. (2000). Association between parental perception of children's vulnerability to illness and management of children's asthma. Pediatric Pulmonology, 29, 88-93. DOI: 10.1002/(SICI) 1099-0496(200002)29:2<88::AID-PPUL2>3.0.CO;2-D.
39. Tabachnick, B. G., & Fidell, L. S. (1989). Using multivariate statistics (2nd edn.). Cambridge, MA: Harper & Row.
40. Thomasgard, M. (1998). Parental perceptions of child vulnerability, overprotection, and parental psychological characteristics. Child Psychiatry and Human Development, 28, 223-240. DOI: 10.1023/A:1022631914576.
41. Thomasgard, M., & Metz, W. P. (1996). The two-year stability of parental perceptions of child vulnerability and parental protectiveness. Journal of Developmental and Behavioral Pediatrics, 17, 222-228.
42. Thomasgard, M., & Metz, W. P. (1997). Parental overprotection and its relation to perceived child vulnerability. American Journal of Orthopsychiatry, 67, 330-335. DOI: 10.1037/h008 0237.
43. Thomasgard, M., Shonkoff, J. P., Metz, W. P., & Edelbrock, C. (1995). Parent-child relationship disorders. Part II. The vulnerable child syndrome and its relation to parental overprotection. Developmental and Behavioral Pediatrics, 16, 251-256. Retrieved from.
44. Tluczek, A., Clark, R., Koscik, R. L., & Farrell, P. M. (2005). Mother-infant relationships in the context of neonatal CF diagnosis: Preliminary findings. Pediatric Pulmonology, 28, 179-180. Retrieved from.
45. Tluczek, A., Koscik, R. L., Farrell, P. M., & Rock, M. J. (2005). Psychosocial risk associated with newborn screening for cystic fibrosis: Parents' experience while awaiting the sweat-test appointment. Pediatrics, 115, 1692-1703. DOI: 10.1542/peds.2004-0275.
46. Tluczek, A., Orland, K. M., & Cavanagh, L. (2011). Psychosocial consequences of false-positive newborn screen for cystic fibrosis: A relational family system perspective. Qualitative Health Research 21, 174-186. [Epub 2010 Sep 17]. DOI: 10.1177/1049732310382919.
47. United States Census Bureau. (16-Aug-2010). Retrieved from.
48. Waisbren, S. E., Albers, S., Amato, S., Ampola, M., Brewster, T. G., Demmer, L., Levy, H. L. (2003). Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA, 290, 2564-2572. DOI: 10.101/jama.290.19.2564.
49. Wang, X., Kim, J., McWilliams, R., & Cutting, G. R. (2005). Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Archives of Otolaryngology-Head & Neck Surgery, 131, 237-240. Retrieved from.